54 results
Page 2 of 3
8-K
EX-1.1
p3fllr249jgi
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
rz8bm w8v
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
ye4tp0o3ksqpo0
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
k7g3y
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
tnfgbaamk800f38cd
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
0poiulir
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
wwbz l9gln
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
c3nun51m19cbgdwtg
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
8-K
nb36ajng84a018
30 May 19
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
blvtf4xg
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
DEF 14A
3m9mxii6v p4
30 Apr 19
Definitive proxy
4:04pm
10-K
elciqzfzcif6q9
22 Mar 19
Annual report
4:45pm
424B4
odua9l
8 Feb 19
Prospectus supplement with pricing info
4:40pm
CORRESP
8bts9do32zdmsjz
5 Feb 19
Correspondence with SEC
12:00am